Mohammed Asadullah Khan

Title: Mohammed Asadullah Khan: Innovator in Pharmaceutical Science

Introduction

Mohammed Asadullah Khan is a notable inventor based in Scarborough, Canada. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target critical biological processes.

Latest Patents

Khan holds two patents, with his latest focusing on crystalline forms of a CD73 inhibitor. This invention describes crystalline forms of the compound of Formula (I), which modulates the conversion of AMP to adenosine by 5'-nucleotidase, ecto. The patent outlines compositions containing the compound and methods for preparing these crystalline forms. Furthermore, it details the use of such crystalline forms and compositions for the treatment and prevention of various diseases, disorders, and conditions, including cancer and immune-related disorders mediated by 5′-nucleotidase, ecto.

Career Highlights

Khan is currently associated with Arcus Biosciences, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for complex diseases.

Collaborations

Some of his notable coworkers include Andrew M K Pennell and Eric F Connor, who contribute to the innovative environment at Arcus Biosciences, Inc.

Conclusion

Mohammed Asadullah Khan's work exemplifies the intersection of innovation and healthcare, showcasing the potential of scientific advancements in improving patient outcomes. His contributions to the field are invaluable and continue to inspire future research.